Wednesday, 15 August 2018 - 9:58
  • it
  • de
  • en
  • fr


Acquisition of Akorn by Fresenius at risk: Akorn sinks, -33%

German healthcare group Fresenius yesterday announced that it is investigating alleged breaches of FDA data integrity requirements relating to product development by Akorn. Fresenius acquired US-based Akorn one year ago for $4.3bn including debt. Should investigation confirm Fresenius’ suspicions before…

Fresenius targeting US-based Akorn

German healthcare company Fresenius SE & Co KGaA announced on Friday evening that subsidiary Fresenius Kabi is in advanced talks to acquire US-based generic drugmaker Akorn. Akorn has a market value of approximately $3.7bn and five manufacturing sites in Decatur…